Descripción
Deca200™
Nandrolone Decanoate
200 mg/ml.
Description: Nandrolone decanoate, sold under the brand name Deca-durabolin among others, is an androgen and anabolic steroid (AAS) medication which is used primarily in the treatment of anemias and wasting syndromes, as well as osteoporosis in menopausal women.
Medical uses: Therapeutically it is used for the treatment of certain types of anemia, since its use increases the number of red blood cells, hemoglobin and hematocrit.
Non-medical uses: Due to the fact that Deca200™ mg also stores water in the connective tissues, it can temporarily relieve or even cure existing joint pains. Deca200™ is especially good for those athletes who complain of pain in the shoulder, elbow and knee; they can often enjoy pain-free workouts during treatment with Deca200™. «Deca» blocks cortisone receptors, allowing less cortisone to reach muscle cells and connective tissue cells.
Contraindications: Contraindications for nandrolone decanoate include pregnancy, breastfeeding, prostate cancer, male breast cancer, breast cancer in women with hypercalcemia, hypersensitivity (to nandrolone decanoate or excipients such as arachis (peanut) oil; includes those with peanut and soy allergies), nephrosis or nephritis, liver disease with impaired bilirubin excretion, and heart failure..
Possible side effects: The side effects of nandrolone decanoate are dependent on dosage, duration of treatment, and individual sensitivity. A number of common, uncommon, and rare side effects have been observed with the medication at recommended dosages. While less common or severe than with many other AAS, the most common side effect of nandrolone decanoate is virilization (masculinization) in women. Uncommon side effects of nandrolone decanoate at recommended dosages include fluid retention, inhibition of spermatogenesis, testicular atrophy, erectile dysfunction, gynecomastia, increased frequency of penile erections and acne.
Interactions: Antiestrogens like aromatase inhibitors (e.g., anastrozole) and selective estrogen receptor modulators (e.g., tamoxifene) can interfere with and prevent the estrogenic effects of nandrolone decanoate. 5α-Reductase inhibitors like finasteride and dutasteride can prevent the inactivation of nandrolone in so-called «androgenic» tissues like the skin, hair follicles, and prostate gland, and may therefore considerably increase its androgenic side effects. This is opposite to the case of most other AAS, which are either potentiated by 5α-reductase in such tissues or are not substrates of 5α-reductase. Antiandrogens like cyproterone acetate, spironolactone, and bicalutamide can block both the anabolic and androgenic effects of AAS like nandrolone decanoate.
Pharmacology: Nandrolone decanoate is a nandrolone ester, or a prodrug of nandrolone. As such, it is an androgen and anabolic steroid, or an agonist of the AR, the biological target of androgens like testosterone and DHT. Relative to testosterone, nandrolone decanoate has enhanced anabolic effects and reduced androgenic effects. It is considered to have strong anabolic effects but weak androgenic effects, with respective potency ratios of 3.29–4.92 and 0.31–0.41 (index value 10.6–12.1 or about an 11:1 ratio of myotrophic to androgenic effect) relative to testosterone propionate.
Additional information:
• Keep out of the reach of children.
• Do not store at a temperature higher than 30ºC.
• Do not consume Deca200™ after the expiration date.
• Each ml contains 200 mg of Deca200™ (Nandrolone Decanoate).
• Medical prospectus made and approved in August 2018.
